or Try an Advanced Search...

    Technical Analysis for GSD - Devonian Health Group Inc

    Grade Last Price % Change Price Change
    B 0.220 0.00% 0.000
    GSD closed unchanged on Tuesday, April 23, 2024, on 46 percent of normal volume.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Up Flat
    Historical GSD trend table...
    Date Alert Name Type % Chg
    Narrow Range Bar Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Stochastic Sell Signal Bearish 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Overbought Stochastic Strength 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Overbought Stochastic Strength 0.00%
    Gapped Down Weakness 0.00%
    Older End-of-Day Signals for GSD ...

       Recent Intraday Alerts

    Alert Time
    2x Volume Pace 3 days ago
    1.5x Volume Pace 3 days ago
    Fell Below 10 DMA 3 days ago
    Down 1 ATR 16 days ago
    Fell Below Previous Day's Low 16 days ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    GSD Chart by TradingView
    Basic chart:

    Profile

    Devonian Health Group Inc. engages in the development of botanical drugs. Its lead product candidate is Thykamine, which is in Phase IIa clinical trials for the treatment of ulcerative colitis and atopic dermatitis. The company also develops value-added products for dermo-cosmetics, and distributes pharmaceutical products. In addition, it acquires drug and health product licenses. Devonian Health Group Inc. has a strategic alliance with CannTx Life Sciences Inc. for the development of cannabinoid-based pharmaceutical drugs. The company was incorporated in 2013 and is headquartered in Québec, Canada.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Health Pharma Pharmaceutical Clinic Drug Science Drugs Life Sciences Health Sciences Pharmaceutical Products Clinical Trial Cannabinoid Pharmaceutical Industry Medication Ulcer Cosmetics Pharmaceutical Sciences Atopic Dermatitis Colitis Pharmaceutical Drugs Ulcerative Colitis

    Is GSD a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 2 bullish, 1 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 0.68
    52 Week Low 0.11
    Average Volume 18,505
    200-Day Moving Average 0.313
    50-Day Moving Average 0.180
    20-Day Moving Average 0.208
    10-Day Moving Average 0.221
    Average True Range 0.017
    RSI (14) 54.34
    ADX 19.22
    +DI 41.335
    -DI 28.566
    Chandelier Exit (Long, 3 ATRs) 0.198
    Chandelier Exit (Short, 3 ATRs) 0.177
    Upper Bollinger Bands 0.267
    Lower Bollinger Band 0.148
    Percent B (%b) 0.6
    BandWidth 57.267
    MACD Line 0.013
    MACD Signal Line 0.013
    MACD Histogram 0.0006
    Fundamentals Value
    Market Cap 13.81 Million
    Num Shares 62.8 Million
    EPS -0.05
    Price-to-Earnings (P/E) Ratio -4.58
    Price-to-Sales 3.69
    Price-to-Book 1.16
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.220
    Resistance 3 (R3) 0.220 0.220 0.220
    Resistance 2 (R2) 0.220 0.220 0.220 0.220
    Resistance 1 (R1) 0.220 0.220 0.220 0.220 0.220
    Pivot Point 0.220 0.220 0.220 0.220 0.220
    Support 1 (S1) 0.220 0.220 0.220 0.220 0.220
    Support 2 (S2) 0.220 0.220 0.220 0.220
    Support 3 (S3) 0.220 0.220 0.220
    Support 4 (S4) 0.220